Publications for Anna K Jönsson
Co-author map based on ISI articles 2007-

Publications mentioned in social media 11 times*

Keywords

vte tramadol suspected substances risk reactions patients morbidity intoxications incidence fatal drugs drug-related drug detected death cause antipsychotics antipsychotic adverse

Journal Articles

Anna K Jönsson, Carl Soderberg, Ketil Arne Espnes, Johan Ahlner, Anders Eriksson, Margareta Reis and Henrik Druid
  Sedative and hypnotic drugs-Fatal and non-fatal reference blood concentrations
  Forensic Science International, 2014, 236, 138-145.
   Fulltext  PDF  

K M Hakkarainen, H Gyllensten, Anna K Jönsson, K Andersson Sundell, M Petzold and Staffan Hägg
  Prevalence, nature and potential preventability of adverse drug events - A population-based medical record study of 4970 adults
 
Altmetric usage: 2

  British Journal of Clinical Pharmacology, 2013, , .

Hanna Gyllensten, Clas Rehnberg, Anna K Jönsson, Max Petzold, Anders Carlsten and Karolina Andersson Sundell
  Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey.
 
Altmetric usage: 6

  BMJ Open, 2013, 3(6), .
   Fulltext  PDF  

Henrik Lövborg, Anna K Jönsson and Staffan Hägg
  A fatal outcome after unintentional overdosing of rivastigmine patches
  Current drug safety, 2012, 7(1), 30-2.
   Fulltext  PDF  

Anna K. Jönsson, Olav Spigset and Staffan Hägg
  Venous Thromboembolism in Recipients of Antipsychotics: Incidence, Mechanisms and Management
 
Altmetric usage: 1

  CNS Drugs, 2012, 26(8), 649-662.
 Web of Science® Times Cited: 6

Hanna Gyllensten, Anna K Jönsson, Clas Rehnberg and Anders Carlsten
  How are the Costs of Drug-Related Morbidity Measured?: A Systematic Literature Review
 
Altmetric usage: 1

  Drug Safety, 2012, 35(3), 207-219.
 Web of Science® Times Cited: 1

Ingela Jacobsson, Anna K Jönsson, Barbro Gerdén and Staffan Hägg
  Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden.
  Pharmacoepidemiology and drug safety, 2009, , .
 Web of Science® Times Cited: 21

Anna Jonsson, Olav Spigset, Micaela Tjäderborn, Henrik Druid and Staffan Hägg
  Fatal drug poisonings in a Swedish general population.
  BMC clinical pharmacology, 2009, 9(7), 1-5.
   Fulltext  PDF  

Anna K. Jönsson, Erzsebet Horváth-Puhó, Staffan Hägg, Lars Pedersen and Henrik T Sörensen
  Antipsychotics and risk for venous thromboembolism: A population based case-control study
  Clinical Epidemiology, 2009, 1, 19-26.
   Fulltext  PDF  

Anna Jönsson, Lars Brudin, Johan Ahlner, Karin Hedenmalm, Anders Eriksson and Staffan Hägg
  Antipsychotics associated with pulmonary embolism in a Swedish medicolegal autopsy series
  International Clinical Psychopharmacology, 2008, 23(5), 263-268.

Karin Wester, Anna K. Jönsson, Olav Spigset, Henrik Druid and Staffan Hägg
  Incidence of fatal adverse drug reactions: A population based study
 
Altmetric usage: 1

  British Journal of Clinical Pharmacology, 2008, 65(4), 573-579.
 Web of Science® Times Cited: 55

Karin Wester, Anna Jönsson, Olav Spigset and Staffan Hägg
  Spontaneously reported fatal suspected adverse drug reactions: A 10-year survey from Sweden
  Pharmacoepidemiology and Drug Safety, 2007, 16(2), 173-180.
 Web of Science® Times Cited: 10

Anna Jönsson, Per Holmgren, Henrik Druid and Johan Ahlner
  Cause of death and drug use pattern in deceased drug addicts in Sweden, 2002-2003
  Forensic Science International, 2007, 169(2-3), 101-107.
 Web of Science® Times Cited: 23

Micaela Tjäderborn, Anna Jönsson, Staffan Hägg and Johan Ahlner
  Fatal unintentional intoxications with tramadol during 1995-2005
  Forensic Science International, 2007, 173(2-3), 107-111.
 Web of Science® Times Cited: 13

Anna K. Jönsson, Olav Spigset, Ingela Jacobsson and Staffan Hägg
  Cerebral haemorrhage induced by warfarin - the influence of drug-drug interactions
  Pharmacoepidemiology and Drug Safety, 2007, 16(3), 309-315.
 Web of Science® Times Cited: 15

Anna Jönsson, Ingela Jacobsson, Mats Andersson and Staffan Hägg
  Stor underrapportering av hjärnblödning som läkemedelsbiverkning
  Läkartidningen, 2006, 103, 3456-3458.

Christina Hedman, Jan Frystyk, Karin Fridell, Anna Jönsson, Allan Flyvbjerg, Torbjörn Lindström and Hans Arnqvist
  The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes
  Growth Hormone & IGF Research, 2005, 15(4), 304-310.
 Web of Science® Times Cited: 3

Anna Jönsson, Per Holmgren and Johan Ahlner
  Fatal intoxications in a Swedish forensic autopsy material during 1992-2002
  Forensic Science International, 2004, 143(1), 53-59.
 Web of Science® Times Cited: 30

Conference Articles

Micaela Tjäderborn, Anna Jönsson, Johan Ahlner and Staffan Hägg
  Tramadol Dependence: A Survey of Spontaneously Reported Cases in Sweden
  24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2008.


Ingela Jacobsson, M Danell Boman, Anna Jönsson and Staffan Hägg
  Who Reports Suspected Adverse Drug Reactions to the Spontaneous Reporting System in Sweden?
  24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2008.


Micaela Tjäderborn, Anna Jönsson, Johan Ahlner and Staffan Hägg
  Tramadolberoende: En studie av spontanrapporterade fall i Sverige 1995-2006
  Läkarstämman, Göteborg, 2008.


Anna Jönsson, Ingela Jacobsson, Karolina Andersson, Staffan Hägg and Anders Sundström
  Factors Predisposing an Abstract To Be Accepted for Oral Presentation
  Pharmacoepidemiology and drug safety, 2008.


Anna Jönsson, Henrik Sörensen, Erzébet Horváth-Puhó and Staffan Hägg
  Association between Venous Thromboembolism and Antipsychotics: A Population Based Case-Control Study
  Pharmacoepidemiology and Drug Safety, 2007.


Ingela Jacobsson, Anna Jönsson, Barbro Gerdén, Cecilia Axling and Staffan Hägg
  Spontaneously Reported Suspected Adverse Drug Reactions in Association with Complementary and Alternative Medicine Products
  Pharmacoepidemiology and Drug Safety, 2007.


Karin Wester, Anna Jönsson and Staffan Hägg
  Incidence of Suspected Drug-Related Deaths in a Swedish Population
  Pharmacoepidemiology and drug safety, 2007.


Karin Wester, Anna Jönsson, Olav Spigset, Henrik Druid and Staffan Hägg
  Incidens av läkemedelsrelaterad dödslighet i Sverige
  Läkarsällskapets Riksstämma,2007, 2007.


Anna Jönsson, Lars Brundin, Johan Ahlner, Karin Hedenmalm, Anders Eriksson and Staffan Hägg
  Low-potency and atypical antipsychotics were associated with pulmonary embolism among Swedish autopsy cases
  International conference on Pharmacoepidemiology Therapeutic risk management,2006, 2006.


Karin Wester, Anna Jönsson, Olav Spigset and Staffan Hägg
  Spontaneously reported fatal adverse drug reactions: a 10-year survey from Sweden
  International conference on Pharmacoepdemiology Therapeutic risk management,2006, 2006.


Anna Jönsson, Henrik Druid and Johan Ahlner
  Narkotikarelaterade dödsfall och missbruksmönster i Sverige 2002-2003
  Mobilisering mot narkotika, Forskningsdagarna,2005, 2005.


Anna Jönsson and Johan Ahlner
  Benzodiazepiner, bruk och missbruk
  Det förbisedda missbruket - läkemedlens del i beroendeproblematiken, Mobilisering mot narkotika,2005, 2005.


Anna Jönsson, Mats Andersson, Ingela Jacobsson and Staffan Hägg
  Stor underrapportering av hjärnblödningar under warfarinbehandling
  Läkarsällskapets Riksstämma,2005, 2005.


Karin Wester, Anna Jönsson and Staffan Hägg
  Fatala läkemedelsbiverkningar - spontanrapporterade fall i Sverige 1995 - 2004
  Läkarsällskapets Riksstämma,2005, 2005.


Anna Jönsson, Mats Andersson, Ingela Jacobsson and Staffan Hägg
  Large underreporting of cerebral haemorrhage during warfarin treatment in Sweden
  7th Congress of European association for clinical pharmacology,2005, 2005.


Ph.D. Theses

Anna K. Jönsson
  Drug-related morbidity and mortality: Pharmacoepidemiological aspects
  2007.


  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.